Navigation Links
DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook'
Date:10/11/2007

WASHINGTON, DC The U.S. Department of Energys Office of Science today released a comprehensive update of its landmark 2003 publication, Facilities for the Future of Science: A Twenty-Year Outlook, that shows the agency has made significant progress in deploying the scientific facilities and instruments that the United States needs to capture world scientific leadership, extend the frontiers of science and support the Departments missions.

When it was published four years ago, the Facilities Outlook was the first long-range facilities plan prioritized across disciplines ever issued by a government science funding agency anywhere in the world. It remains so today and serves a model for other countries and regions that are developing roadmaps for research infrastructures.

The 2003 plan listed 28 new scientific facilities and upgrades of current facilities that will define scientific opportunities over the next 20 years in all fields of science supported by the Office of Science, including fusion energy, advanced scientific computation, materials science, biological and environmental science, high energy physics and nuclear physics. The facilities were ranked according to their scientific importance and readiness for construction, and they spanned scientific fields to ensure the U.S. retains its primacy in critical areas of science and technology well into this century.

The world-leading scientific facilities we create, maintain and operate are key to continued U.S. leadership in physical and biological research, writes Under Secretary for Science Dr. Raymond L. Orbach in the introduction of Four Years Later: An Interim Report on Facilities for the Future of Science: A Twenty-Year Outlook. This leadership, and the transformational scientific discoveries that flow from it, are critical to meeting the challenges our Nation faces in the twenty-first century in the areas of both global economic competitiveness and energy securi
'/>"/>

Contact: Jeff Sherwood
jeff.sherwood@hq.doe.gov
202-586-4826
DOE/US Department of Energy
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. PLoS Medicine publishes first trial of effect of male circumcision on HIV infection
2. DOE publishes research roadmap for developing cleaner fuels
3. Origen publishes in Nature a robust and versatile method for creating transgenic chickens
4. Marburg virus disease in Angola - update
5. Marburg haemorrhagic fever in Angola update
6. Updated data on novel HPV vaccine confirms efficacy in large population
7. MBL leads effort to update E. coli genome
8. Research updates 65-year-old genetic discovery
9. Mitochondrial DNA sequencing tool updated
10. Update on census of worlds most endangered cat -- Female Amur leopard found dead
11. HIV vaccine trial breaks ground for future research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...rain of the deadly superbug MRSAan infection-causi...ses a far greater health threat than previously kn...g to a study in the December issue of Emerging In...picked up in fitness centers, schools, and other p...of MRSA within hospitals, the report found. , Th...
(Date:11/23/2009)...t a common oral bacterium may exacerbate autoimmun...Unique Lipids from a Common Human Bacterium Repres...ng Autoimmunity," appears in the December 2009 iss...tiple sclerosis (MS), a disease where the immune s...early 1 in 700 people in the United States. Patie...
(Date:11/23/2009)...ty of Alabama at Birmingham (UAB) researchers show...al conditions (co-morbidity) do not explain the de...compared to Caucasians who also have colon cancer...., a journal of the American Cancer Society. , Th...dity are independent predictors of poor survival f...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2J W Bill Marriott to Receive Churchill Centre Award For Leadership 61023 1J W Bill Marriott to Receive Churchill Centre Award For Leadership 61023 2Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week 61021 1Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week 61021 2BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 1BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 2BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 3BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 4BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 5BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 6BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 7BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 8BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 9BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 10BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 11BMP Sunstone Reports Third Quarter 2009 Financial Results 14771 12
...s of cancer continues to pose a major problem for ... forms of chemotherapy or become resistant to the ... Infection Research (HZI) in Braunschweig, the Han...(LUH) in Hanover have now discovered a chemical me... destroys tumours. Today, the researchers publish ...
...of on-the-go crop and soil sensors has greatly inc... their crops. Recently released research in Agron...ment is necessarily more efficient. They discovere...recision agriculture, calculating how large of an ...nt techniques. According to the authors, this chan...
...h . , Barcelona, Spain: Couples who need IVF i...his will not lead to developmental problems in ear...l conference of the European Society of Human Repr.... Karin Middelburg, from the University Medical Ce...hat the study, which looked at the quality of gene...
Other Biology News:Argyrin: Natural substance raises hope for new cancer therapies 2IVF does not increase risk of developmental disorders in children 2
(Date:11/24/2009)...PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: S...today,announcedthatithassubmittedaMAAtotheEuropean...nzymereplacementtherapyindevelopment,forthetreatme...plicationforvelaglucerasealfathathasbeensubmitted,.... , Basedonaglobalsupplyshortageofthecurrentl...
(Date:11/24/2009)...Program Connects Customers with Partners Validated... Genotek Products , Ottaw...a leading provider of products for biological samp...y announced its new global partner program. The pr...tek,s partner community and is designed to help pa...
(Date:11/23/2009)... think of it as origami very high-tech origami. ,...eveloped a technique for fabricating three-dimensi...hin films by coupling photolithography and a self-..., The films, only a few microns thick, offer mech...er pieces of the same material. , "This is a comp...
(Date:11/23/2009)....23/PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAm...mpanythatidentifiesandadvancesadiverseportfolioofp...elopment,todayreportedthatCytopia(ASX:CYT)hascomme...otent,orally-administeredJAK1/JAK2inhibitor.Thetri...a.AproposaltomergeCytopiaintoYMhasbeenpreviouslyan...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
...genetic anticancer program at Pharmion - L... - Sirtuins implicated in tumor developmen...re combination epigenetic therapies, BOULDER, Col...sdaq: PHRM ) and MethylGene Inc. (TSX: MYG) today...pment of novel small molecule,inhibitors targeting...
... CLAREMONT, Calif., Aug. 14 /Xinhua-PRNewswire-Fir...n (OTC Bulletin Board: KWBT),announced that revenu...han,35% over the first quarter of 2007 exceeding $...351 for the same period in the previous year. Rev...ompared to only,$24,374 in the first half of 2006....
...d., Aug. 14 Martek Biosciences,Corporation announ...third,quarter of fiscal 2007 on September 5, 2007,...(EDT). Following the release, at 4:45 p.m. EDT Mar...ults of its third quarter of,fiscal 2007 with inve...e,hour in duration. The conference call will also ...
Other Biology Technology:Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 2Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 3Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 4Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 5Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 6Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 2Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 3Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 4Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 5Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 6Martek to Announce Third Quarter 2007 Results on September 5, 2007 2
Mouse Anti-Human Non-SMC condensin II complex, subunit D3 (NCAPD3) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
TSQ Quantum Discovery MAX from Thermo Scientific
Flp-In T-REx Core Kit from Invitrogen
BD Falcon 1536-well Black Microplates from BD Biosciences - Discovery Labware
Biology Products: